Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact
In acute stroke, serum GFAP levels show potential as an adjunct tool for the distinction between ICH and AIS. Specific to AIS, GFAP may also offer insight into time from onset, and extent of ischemic tissue injury on neuroimaging, particularly in LVO stroke. These preliminary findings merit further study.
Authors
- Célina Ducroux (ORCID: https://orcid.org/0000-0001-8938-9494)
- Audrey Daigneault
- Laura C. Gioia (ORCID: https://orcid.org/0000-0001-7382-4973)
- Christian Stapf (ORCID: https://orcid.org/0000-0002-3193-1006)
- Pamela Correia (ORCID: https://orcid.org/0000-0002-2414-2367)
- Catherine Larochelle (ORCID: https://orcid.org/0000-0002-8724-4782)
- Julien F. Paul
Institutions
- Ottawa Hospital (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3389/fneur.2024.1470718
- Citations
- 8
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 3.09